Tp10 (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
223 | Primary membranoproliferative glomerulonephritis | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02302755 (ClinicalTrials.gov) | November 2014 | 5/11/2014 | TP10 Use in Patients With C3 Glomerulopathy (C3G) | A Pilot, Open-Label Single Center Trial of TP10 in Pediatric and Adult Patients With C3 Glomerulopathy (C3G) | Dense Deposit Disease | Drug: TP10 | University of Iowa | NULL | Withdrawn | 4 Years | N/A | Both | 0 | Phase 1 | United States |